Saying goodbye (today)

I'm incredibly impressed by the urgent stock market warning our good friend Joel Litman has been sharing with you for the last week. [DailyWealth] Dear Reader, I'm incredibly impressed by [the urgent stock market warning our good friend Joel Litman has been sharing with you for the last week.]( Joel waited 20 years to unveil this strategy to the public... but it's coming offline tonight. Before it does, there's something more going on here that you should understand... So, I'm asking you to please read this short message in full. Because I'm 100% sure that [this approach is the single most important thing I can show you today.]( It's the key to protecting yourself in the serious downturn Joel is predicting, beginning now. (And please remember, he predicted the 2008 crash three months in advance. So his warnings are always time-sensitive.) This is where Joel thinks everyone should have most of their money for at least the next few years. Just remember: The deadline is MIDNIGHT TONIGHT. So, if you haven't seen his presentation yet, for whatever reason... [Please go here now and see it while you still can.]( You're about to get a massive amount of value out of what Joel's shared on camera, even if you never spend a single penny on his research. - He's laid out his big stock market warning, in full, with all the evidence... - He's revealed what he considers [the biggest secret in finance]( – which has been deliberately kept from you your whole life (and can quickly make you better at every kind of investing)... - And he gave you the entire, detailed strategy he and his team have used to see triple-digit returns even when stocks do terribly, like they did in 2008. That said, the strategy you're about to see remains one of the best approaches in the world in any market... But [the opportunities are going to be 5x-10x better]( over the next several years for reasons you'll clearly understand when you see this. Joel already has very deep-pocketed professional clients who pay an arm and a leg for his research – up to $100,000 per month. Research that gives them the kind of "edge" in the markets that ordinary folks pretty much never have. Our friends at Altimetry share our mission here at Stansberry – to share [that exact same kind of research]( with everybody. And while, yes, it's a business... I always want to show you our best and most important ideas completely for free. Especially in moments like this – when your retirement hopes could be on the line in the next few years. [See for yourself, right here.]( I know from experience that some folks will inevitably miss out. They'll refuse to try something new... keep chasing a market bubble... keep swinging for home runs on speculative investments... with predictable results. Or sit with parked cash in a near-zero yield account while inflation continues to eat away at its value. But I want to make sure that YOU are part of the small group that says "yes"... And [start collecting double-digit potential income and triple-digit potential capital gains]( in one of the simplest and least risky strategies on the planet. If you've truly thought this over and decided it's not for you – of course, I respect your decision. And I'm grateful for your time and attention. But I'm asking you: [Please give this careful consideration today.]( After tonight, this will disappear forever. Sincerely, Brett Aitken Publisher, Stansberry Research Published by Stansberry Research. You have received this e-mail as part of your subscription to DailyWealth. If you no longer wish to receive special offers from DailyWealth, [click here](. You’re receiving this e-mail at {EMAIL}. Stansberry Research welcomes comments or suggestions at feedback@stansberryresearch.com. This address is for feedback only. For questions about your account or to speak with customer service, call 888-261-2693 (U.S.) or 443-839-0986 (international) Monday-Friday, 9 a.m.-5 p.m. Eastern time. Or e-mail info@stansberryresearch.com. Please note: The law prohibits us from giving personalized financial advice. © 2024 Stansberry Research. All rights reserved. Any reproduction, copying, or redistribution, in whole or in part, is prohibited without written permission from Stansberry Research, 1125 N Charles St, Baltimore, MD 21201 [stansberryresearch.com](.